Rutgers study finds patients with schizophrenia are less likely to be rehospitalized when given antipsychotic injections

From Philly and the Pa. suburbs to South Jersey and Delaware, what would you like WHYY News to cover? Let us know!

Long-acting injectable medications for schizophrenia can decrease the likelihood of patient rehospitalizations, according to a new Rutgers University Health study.

In their findings, published in the Journal of Clinical Psychopharmacology, researchers concluded that compared to oral antipsychotics, injections accounted for a 75% reduction of hospital readmissions.

Rutgers Health analyzed data pulled from hospital systems where patients were discharged with schizophrenia or schizoaffective-related disorders from August 2019 to June 2022.

Of total discharged patients, 240 individuals were given oral medications while 103 opted for long-acting injections.

The results showed that patients given antipsychotics in pill form had a hospital readmission rate of 8.3% over a 30-day period. Meanwhile, of patients that were administered drugs by injection, less than 2% returned to the hospital within a month.

  • February 4, 2024
  • Articles,
  • This post was written by